A study to evaluate efficacy and safety of telitacicept in the treatment of patients with primary IgA nephropathy at high risk of progression.
Phase:
NA
Details
Lead Sponsor:
Ruijin Hospital
Collaborators:
Huashan Hospital RenJi Hospital Renmin Hospital of Wuhan University Shanghai 6th People's Hospital Shanghai Changzheng Hospital Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Shanghai Longhua Hospital Sichuan Provincial People's Hospital Songjiang Hospital Affiliated to Shanghai Jiaotong University School of Medicine Wannan Medical College Yijishan Hospital Xinhua Hospital, Shanghai Jiao Tong University School of Medicine